Lapatinib is First Treatment for Rare, Aggressive Cancer
In the first international, multi-center clinical trial of a therapy specific to inflammatory breast cancer (IBC), researchers found that an experimental biologic agent, lapatinib, successfully and specifically treats this rare and aggressive form of cancer....
Please follow this link to read the entire article: CancerWise-January 2007